착상전 유전자 검사 시장 규모, 점유율, 동향 분석 보고서 : 시술별, 제품별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Preimplantation Genetic Testing Market Growth & Trends:

The global preimplantation genetic testing market size is expected to reach USD 1.28 billion by 2030, registering a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Recent technological advancements in testing have changed the current practice of prenatal screening and early detection of chromosomal abnormalities in an embryo. Moreover, the introduction of novel technologies such as NGS, PCR, and FISH is expected to drive market growth over the forecast period.

Growing awareness about genetic diseases and novel techniques for the detection of chromosomal abnormalities and embryo screening for successful IVF holds growth prospects for this vertical over the forecast period. Key market players and service providers such as COOPER SURGICAL, INC. are running awareness campaigns to promote an increased understanding of the diseases and screening of these diseases at the early stages. Such favorable initiatives are expected to increase the demand for PDT in IVF procedures globally.

The increasing adoption of in vitro fertilization (IVF) technique consequently upsurges the utilization of preimplantation genetic testing (PGT). These techniques are advantageous in allowing the development of a healthy fetus and preventing the risk of selective pregnancy termination. Hence, PGT acts as an addendum to assisted reproductive technology.

Moreover, the increased risk of genetic disease in newborns and complications associated with IVF procedures push healthcare providers to recommend PGT. For instance, according to the CDC, in the U.S., about 6,000 babies are born with Down syndrome each year. It is the most common chromosomal condition diagnosed in newborns in the country. Moreover, the high risk associated with aged pregnancy further increases the adoption of PGT worldwide.

Key companies are involved in developing novel methods and solutions to carry out preimplantation genetic diagnosis and screening. To maintain their significant share in the revenue in the coming years, these participants are undertaking strategic initiatives. The strategic undertakings include regional expansion, collaborative development, and new product developments.

For instance, in October 2022, Ovation Fertility and Genomic Prediction partnered to expand genetic testing services by using the LifeView PGT platform for PFT. Moreover, in April 2022, Clevergene received PCPNDT for prenatal genetic testing. The company aimed to expand its services in preimplantation genetic screening and non-invasive prenatal testing.

Preimplantation Genetic Testing Market Report Highlights:

• The reagents and consumables segment dominated the preimplantation genetic testing market and contributed 50.0% of the market share in 2024. In 2024, the instruments segment held the second-largest share of the preimplantation genetic testing industry.
• The Polymerase Chain Reaction (PCR) segment dominated the preimplantation genetic testing industry and contributed 39.6% to the market share in 2024. Next-generation sequencing (NGS) is projected to grow at the fastest CAGR during the forecast period.
• The aneuploidy screening segment dominated in 2024 and contributed 26.0% of the market share. In 2024, the HLA typing segment accounted for the second-largest market share.
• In 2024, the hospital segment captured the largest revenue share, accounting for approximately 39.3%. Fertility centers are expected to emerge as the most lucrative of all over the forecast period.
• The Europe preimplantation genetic testing market dominated the global market in 2024, capturing the largest revenue share at 34.65%. Asia Pacific preimplantation genetic testing industry is anticipated to witness the fastest CAGR of 7.4% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. Product
  • 1.2.3. Technology
  • 1.2.4. Application
  • 1.2.5. End Use
  • 1.2.6. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Preimplantation Genetic Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising incidences of genetic diseases
    • 3.2.1.2. Demand for healthy and successful embryo implantation
    • 3.2.1.3. Increase in rate of infertility
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Ethical and legal constraints
• 3.3. Preimplantation Genetic Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. Preimplantation Genetic Testing Market: Procedure Estimates & Trend Analysis

• 4.1. Procedure Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Global Preimplantation Genetic Testing Market by Procedure Outlook
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Preimplantation Genetic Screening
  • 4.5.1. Preimplantation genetic screening market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Preimplantation Genetic Diagnosis
  • 4.6.1. Preimplantation genetic diagnosis market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Preimplantation Genetic Testing Market: Product Estimates & Trend Analysis

• 5.1. Product Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Global Preimplantation Genetic Testing Market by Product Outlook
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Reagents and Consumables
  • 5.5.1. Reagents and Consumables market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Instruments
  • 5.6.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Software
  • 5.7.1. Software market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Preimplantation Genetic Testing Market: Technology Estimates & Trend Analysis

• 6.1. Technology Market Share, 2024 & 2030
• 6.2. Segment Dashboard
• 6.3. Global Preimplantation Genetic Testing Market by Technology Outlook
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Next Generation Sequencing (NGS)
  • 6.5.1. Next Generation Sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Polymerase Chain Reaction (PCR)
  • 6.6.1. Polymerase Chain Reaction (PCR) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Fluorescent In-Situ Hybridization (FISH)
  • 6.7.1. Fluorescent In-Situ Hybridization (FISH) market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Preimplantation Genetic Testing Market: Application Estimates & Trend Analysis

• 7.1. Application Market Share, 2024 & 2030
• 7.2. Segment Dashboard
• 7.3. Global Preimplantation Genetic Testing Market by Application Outlook
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Chromosomal Abnormalities
  • 7.5.1. Chromosomal abnormalities market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. X-linked Diseases
  • 7.6.1. X-linked Diseases market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Embryo Testing
  • 7.7.1. Embryo Testing market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Aneuploidy Screening
  • 7.8.1. Aneuploidy Screening market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. HLA Typing
  • 7.9.1. HLA Typing market estimates and forecasts 2018 to 2030 (USD Million)
• 7.10. Others
  • 7.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Preimplantation Genetic Testing Market: End Use Estimates & Trend Analysis

• 8.1. End Use Market Share, 2024 & 2030
• 8.2. Segment Dashboard
• 8.3. Global Preimplantation Genetic Testing Market by End Use Outlook
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. Fertility Centers
  • 8.5.1. Fertility centers market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Hospitals
  • 8.6.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. Diagnostic Centers
  • 8.7.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)
• 8.8. Research Centers and Academic Labs
  • 8.8.1. Research centers and academic labs market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Preimplantation Genetic Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Global Regional Market Snapshot
• 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 9.5. North America
  • 9.5.1. U.S.
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Canada
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. UK
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Germany
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. France
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. Italy
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Spain
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Norway
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Sweden
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Denmark
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Regulatory framework
    • 9.6.8.3. Competitive scenario
    • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Japan
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. China
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. India
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. Australia
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. South Korea
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Regulatory framework
    • 9.7.5.3. Competitive scenario
    • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. Thailand
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Regulatory framework
    • 9.7.6.3. Competitive scenario
    • 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Brazil
    • 9.8.1.1. Key country dynamics
    • 9.8.1.2. Regulatory framework
    • 9.8.1.3. Competitive scenario
    • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Argentina
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. South Africa
    • 9.9.1.1. Key country dynamics
    • 9.9.1.2. Regulatory framework
    • 9.9.1.3. Competitive scenario
    • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. Saudi Arabia
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Regulatory framework
    • 9.9.2.3. Competitive scenario
    • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. UAE
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Regulatory framework
    • 9.9.3.3. Competitive scenario
    • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. Kuwait
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Regulatory framework
    • 9.9.4.3. Competitive scenario
    • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Key company market share analysis, 2023
  • 10.3.4. Quest Diagnostics Incorporated
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Services benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Natera, Inc
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Services benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. COOPER SURGICAL, Inc
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Services benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Genea Pty Limited
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Services benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Thermo Fisher Scientific, Inc.
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Services benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Laboratory Corporation Of America Holdings
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Services benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Illumina, Inc.
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Services benchmarking
    • 10.3.10.4. Strategic initiatives